However, based on the age‐specific incidence rates of breast and ovarian cancer, we recommend bilateral oophorectomy at age 35 in BRCA1 carriers and at age 40 in BRCA2 carriers. The gene discussed is BRCA1; the disease is ovarian carcinoma.